Articles

Thanks to advancements in science and medicine, prostate cancer can now be defeated even in its late stages, even when metastases have spread. At AiroMedical, we have gathered real stories from cancer patients and insights from doctors on how to combat the disease effectively. We want to share one prostate cancer story from one of our patients from the USA.

Lu-177 PSMA therapy is targeted radionuclide therapy used to treat prostate cancer. PSMA is an abbreviation for prostate-specific membrane antigen, a protein highly expressed in prostate cancer cells. Lu-177 is a radioactive isotope attached to a molecule that binds specifically to PSMA, delivering high doses of radiation into the cancer cells. This therapy is minimally invasive, has few side effects, and effectively reduces symptoms and improves the quality of life for patients with advanced prostate cancer.

The CyberKnife system is a non-invasive and painless alternative to surgery in treating oncology. Radiation harmful to malignant cells is directed precisely at the tumor without damaging healthy tissues. Today, this method gives hope to people with inoperable and hard-to-reach tumors. It is also an alternative for those who want to avoid surgical treatment and severe complications of chemotherapy and traditional radiation therapy.

Hard-to-reach, deeply located tumors remain a significant problem in oncology. Until recently, doctors could only remove them surgically. A lot of the brain tumors were considered incurable. Gamma Knife radiosurgery sometimes becomes the choice of the best neurosurgeons in the world in treating brain disorders and removing a brain tumor without a scalpel and blood.

Proton therapy is a modern alternative to traditional cancer treatment. Compared with radiotherapy, which works on a similar principle, it is much safer. This factor is essential in treating children, the elderly, and vulnerable people. Over the 14 years of the method's existence, more than 170.000 people have undergone proton treatment for cancer.

Lung cancer is the second most frequent type of cancer worldwide and is the most common reason for death. This disease accounted for 2.1 million new cases and 1.8 million deaths in 2021. The lack of evident symptoms in the early stages means that the illness is often detected too late. Early detection strategies are essential in the treatment of lung tumours. This type of cancer defies medicine, doctors, and the world's health policy.